4. Prospective Micro-Bypass Implantation for To report the long-term follow-up results in 2015 randomised controlled Primary Open-Angle Glaucoma patients with cataract and primary 48 months follow-up trial Combined with Phacoemulsification: glaucoma (POAG) randomly assigned of Fea 2010 study 4-Year Follow-Up to cataract surgery combined with Fea AM, Consolandi G, Zola M et al. stent implantation or phacoemulsification alone. 5. Prospective Fluorophotometric Study of the To evaluate the changes in aqueous humor July 2010 randomised controlled Effect of the Glaukos Trabecular dynamics and the efficacy and safety of the trial Microbypass Stent on Aqueous iStent in combination with cataract surgery. Humor Dynamics N = 33 Fernandez-Barrientos Y, J, Martinez-de-la-Casa JM et al. NCT00326066 Trabecular bypass MIGS devices implanted as stand-alone procedures 6. Prospective Prospective unmasked randomized To compare outcomes of subjects with May 2014 randomised controlled evaluation of the iStent inject® open-angle glaucoma (OAG) not controlled trial versus two ocular hypotensive on one medication who underwent either agents in patients with primary implantation of two iStent inject® trabecular open-angle glaucoma. micro-bypass devices or received medical Fea AM, JI, Rekas M et al. therapy consisting of a fixed combination of latanoprost/timolol. N = 192 7. Prospective Prospective, randomized study of To assess the safety and efficacy of one, December 2015 randomised controlled one, two, or three trabecular bypass two, or three trabecular microbypass stents trial stents in open-angle glaucoma in eyes with primary open-angle glaucoma subjects on topical hypotensive (OAG) not controlled on ocular hypotensive medication medication. A total of 119 subjects were Katz LJ, Erb C, Carceller A et al. followed for 18 months postoperatively. NCT01517477 N = 119
4. Prospective randomised controlled trial Micro-Bypass Implantation for Primary Open-Angle Glaucoma Combined with Phacoemulsification: 4-Year Follow-Up Fea AM, Consolandi G, Zola M et al. To report the long-term follow-up results in patients with cataract and primary glaucoma (POAG) randomly assigned to cataract surgery combined with stent implantation or phacoemulsification alone. 2015 48 months follow-up of Fea 2010 study 5. Prospective randomised controlled trial Fluorophotometric Study of the Effect of the Glaukos Trabecular Microbypass Stent on Aqueous Humor Dynamics Fernandez-Barrientos Y, J, Martinez-de-la-Casa JM et al. NCT00326066 To evaluate the changes in aqueous humor dynamics and the efficacy and safety of the iStent in combination with cataract surgery. N = 33 July 2010 Trabecular bypass MIGS devices implanted as stand-alone procedures 6. Prospective randomised controlled trial Prospective unmasked randomized evaluation of the iStent inject® versus two ocular hypotensive agents in patients with primary open-angle glaucoma. Fea AM, JI, Rekas M et al. To compare outcomes of subjects with open-angle glaucoma (OAG) not controlled on one medication who underwent either implantation of two iStent inject® trabecular micro-bypass devices or received medical therapy consisting of a fixed combination of latanoprost/timolol. N = 192 May 2014 7. Prospective randomised controlled trial Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication Katz LJ, Erb C, Carceller A et al. NCT01517477 To assess the safety and efficacy of one, two, or three trabecular microbypass stents in eyes with primary open-angle glaucoma (OAG) not controlled on ocular hypotensive medication. A total of 119 subjects were followed for 18 months postoperatively. N = 119 December 2015